Magnapen 500mg powder for solution for injection vials

Země: Velká Británie

Jazyk: angličtina

Zdroj: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktivní složka:

Ampicillin sodium; Flucloxacillin sodium

Dostupné s:

Wockhardt UK Ltd

ATC kód:

J01CA51

INN (Mezinárodní Name):

Ampicillin sodium; Flucloxacillin sodium

Dávkování:

250mg ; 250mg

Léková forma:

Powder for solution for injection

Podání:

Intramuscular; Intravenous

Třída:

No Controlled Drug Status

Druh předpisu:

Valid as a prescribable product

Přehled produktů:

BNF: 05010103

Informace pro uživatele

MEASURE BAR SHOULD BE 150MM AT 100% SCALE
Customer
Description
Item Code
Profile
Size
Min. Point Size
Market
Language
Proof By
Proof No.
Date
Artwork No.
Pharma
Code
Colours Used
Wockhardt UK Limited
Co-fluampicil (Magnapen) injection leaflet
107018/3
n-a
190 x 470mm
matt.pirie-scott
3
17/11/2015
610826
n/a
Process Black
Keyline (does not print)
[e-mail]
CLEARLY MARK ANY AMENDMENTS ON ONE PROOF AND RETURN TO MPS
WARNING! We cannot accept responsibility for any errors
in this proof after approval. Whilst we take extreme care
at all times to ensure accuracy to our clientʼs brief,
the final responsibility must be taken by our client.
IF YOU SIGN THIS PROOF YOU ARE SIGNIFYING
FULL APPROVAL OF DESIGN AND TEXT.
UK
English
8.5pt (main body) / 9pt (variables)
PACKAGE LEAFLET INFORMATION FOR THE USER
MAGNAPEN 250MG/250MG POWDER FOR SOLUTION
FOR INJECTION OR INFUSION
(AMPICILLIN AND FLUCLOXACILLIN)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE.
-
Keep this leaflet. You may need to read it again.
-
If you have further questions, please ask your doctor or nurse.
-
This medicine has been prescribed for you personally and you should
not pass it on to others. It may harm them, even if their symptoms are
the same as yours
The name of your medicine is Magnapen 250mg/250mg Powder for
Solution for Injection or Infusion. In the rest of this leaflet it is
called
Magnapen Injection.
IN THIS LEAFLET:
1. What Magnapen Injection is and what it is used for
2. Before you are given Magnapen Injection
3. How Magnapen Injection should be given
4. Possible side effects
5. How to store Magnapen Injection
6. Further information
1. WHAT MAGNAPEN INJECTION IS AND WHAT IT IS USED FOR
Magnapen Injection contains two active ingredients, ampicillin and
flucloxacillin which together are known as co-fluampicil. Magnapen
Injection is an antibiotic medicine. It belongs to the penicillin
group
of antibiotics and works by killing bacteria that cause infections.
Magnapen Injection is used to treat a wide range

Charakteristika produktu

OBJECT 1
MAGNAPEN 250MG/250MG POWDER FOR SOLUTION FOR
INJECTION OR INFUSION
Summary of Product Characteristics Updated 22-Apr-2016 | Wockhardt UK
Ltd
1. Name of the medicinal product
Magnapen® 250mg/250mg Powder for Solution for Injection or Infusion
or Co-fluampicil 250mg/250mg
Powder for Solution for Injection or Infusion
2. Qualitative and quantitative composition
Co-fluampicil 500mg Vials contain 250mg ampicillin as ampicillin
sodium with 250mg flucloxacillin as
flucloxacillin sodium (co-fluampicil 250/250).
3. Pharmaceutical form
Powder for Solution for Injection or Infusion
4. Clinical particulars
4.1 Therapeutic indications
Co-fluampicil is indicated for the treatment of severe infections
where the causative organism is
unknown, and for mixed infections involving β-lactamase-producing
staphylococci. Typical indications
include:
_In general practice:_ Chest infections, ENT infections, skin and soft
tissue infections, and infections in
patients whose underlying pathology places them at special risk.
_In hospital_ (prior to laboratory results being available): severe
respiratory tract infections, post-operative
chest and wound infections, septic abortion, puerperal fever;
septicaemia, prophylaxis in major surgery,
infections in patients receiving immuno-suppressive therapy.
The spectrum of activity of co-fluampicil also makes it suitable for
the treatment of many mixed
infections, particularly those where β-lactamase-producing
staphylococci are suspected or confirmed.
Parenteral usage is indicated where oral dosage is inappropriate.
4.2 Posology and method of administration
USUAL ADULT DOSAGE (INCLUDING ELDERLY PATIENTS AND CHILDREN OVER TEN
YEARS):
_Intramuscular/Intravenous: _500mg four times a day_._
USUAL CHILDREN'S DOSAGE:
_Intramuscular/Intravenous: _Under 2 years: quarter adult dose, four
times a day.
2-10 years: half adult dose, four times a day.
The above dosages for adults and children may be doubled where
necessary.
Therapy may be continued for as long as it is indicated by the nature
of infecti